Not currently recruiting at UCLA
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
Summary
- Eligibility
- for males ages 18-130 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Matthew B. Rettig, MD

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Matthew B. Rettig, MD
Professor-in-Residence, Medicine. Authored (or co-authored) 161 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- AstraZeneca
- Links
- Sign up for this study
- ID
- NCT06120491
- Phase
- Phase 3 Prostate Cancer Research Study
- Study Type
- Interventional
- Participants
- Expecting 1800 study participants
- Last Updated